Coralie Bouchiat
École normale supérieure de Lyon
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Coralie Bouchiat.
Infection, Genetics and Evolution | 2015
Coralie Bouchiat; Karen Moreau; Sébastien Devillard; Jean-Philippe Rasigade; Amandine Mosnier; Tom Geissmann; Michèle Bes; Anne Tristan; Gerard Lina; Frédéric Laurent; Lionel Piroth; Nejla Aissa; Xavier Duval; Vincent Le Moing; François Vandenesch; Catherine Chirouze; Elodie Curlier; Cécile Descottes-Genon; Bruno Hoen; Isabelle Patry; Lucie Vettoretti; Pascal Chavanet; Jean-Christophe Eicher; Sandrine Gohier-Treuvelot; Marie-Christine Greusard; Catherine Neuwirth; André Péchinot; Marie Célard; Catherine Cornu; François Delahaye
Infective endocarditis (IE)((1)) is a severe condition complicating 10-25% of Staphylococcus aureus bacteremia. Although host-related IE risk factors have been identified, the involvement of bacterial features in IE complication is still unclear. We characterized strictly defined IE and bacteremia isolates and searched for discriminant features. S. aureus isolates causing community-acquired, definite native-valve IE (n=72) and bacteremia (n=54) were collected prospectively as part of a French multicenter cohort. Phenotypic traits previously reported or hypothesized to be involved in staphylococcal IE pathogenesis were tested. In parallel, the genotypic profiles of all isolates, obtained by microarray, were analyzed by discriminant analysis of principal components (DAPC)((2)). No significant difference was observed between IE and bacteremia strains, regarding either phenotypic or genotypic univariate analyses. However, the multivariate statistical tool DAPC, applied on microarray data, segregated IE and bacteremia isolates: IE isolates were correctly reassigned as such in 80.6% of the cases (C-statistic 0.83, P<0.001). The performance of this model was confirmed with an independent French collection IE and bacteremia isolates (78.8% reassignment, C-statistic 0.65, P<0.01). Finally, a simple linear discriminant function based on a subset of 8 genetic markers retained valuable performance both in study collection (86.1%, P<0.001) and in the independent validation collection (81.8%, P<0.01). We here show that community-acquired IE and bacteremia S. aureus isolates are genetically distinct based on subtle combinations of genetic markers. This finding provides the proof of concept that bacterial characteristics may contribute to the occurrence of IE in patients with S. aureus bacteremia.
Eurosurveillance | 2015
Dupieux C; Blondé R; Coralie Bouchiat; Meugnier H; Michèle Bes; Laurent S; François Vandenesch; Frédéric Laurent; Anne Tristan
We describe two cases of human infections caused by Staphylococcus aureus clonal complex (CC) 75, also called Staphylococcus argenteus, harbouring the Panton-Valentine leucocidin (PVL). These two sporadic cases were community-acquired, and identified in France in 2014. Both had an epidemiological link with Mayotte, an overseas department of France located in the Indian Ocean off the south-eastern African coast. This report illustrates that, contrary to previous descriptions, S. argenteus can acquire important virulence factors and be responsible for severe infections.
PLOS ONE | 2013
Mitra Saadatian-Elahi; Anne Tristan; Frédéric Laurent; Jean-Philippe Rasigade; Coralie Bouchiat; Anne-Gaëlle Ranc; Gerard Lina; Olivier Dauwalder; Jerome Etienne; Michèle Bes; François Vandenesch
Acquisition of nasal Staphylococcus aureus (S. aureus) colonization by contaminated hands is likely an important determinant of its nasal carriage rate in health care and lab setting. The objective of our cross-sectional study was to assess the prevalence of nasal methicillin-sensitive (MSSA) or -resistant Staphylococcus aureus (MRSA) carriage among health care professionals (HCPs) attending an international symposium and to study the association between compliance with hygiene rules, individual-related parameters, and medical conditions with nasal S. aureus carriage in this population. After obtaining consent, two nasal swabs were collected. Nasal MSSA and MRSA carriage was measured by the: i) molecular approach targeting spa, mecA and mecA-orfX junction sequences, and ii) culture on selective S. aureus media combined with mecA molecular detection of isolated strains. Information on compliance with hygiene rules, demographic variables, sector of activity and long-term medication was collected by anonymous questionnaire. The participation rate was 32.3%. In total, 176 subjects from 34 countries were included in the analysis. S. aureus was isolated from the nasal swabs of 57 (32.4%) subjects, of whom 3 (5.3%) harbored MRSA strains. Overall, 123 subjects reported working in microbiology laboratories with direct manipulation of S. aureus, and 29 acknowledged regular contacts with patients. In this exposed population, hydro-alcoholic solutions appeared to have a significant protective effect against nasal S. aureus carriage (OR = 0.36; 95% CI: 0.15–0.85). Hospital work was associated with increased risk of nasal S. aureus carriage (OR = 2.38; 95% CI: 1.07–5.29). The results of this study showed that compliance with basic rules of hygiene, such as the use of hydro-alcoholic solutions, could reduce the risk of nasal S. aureus colonization. Hydro-alcoholic solution could interrupt auto-transmission of the pathogen, consequently decreasing the overall nasal carriage rate, specifically in transient carriers.
Annals of Medicine | 2017
Yohan N’Guyen; Xavier Duval; Matthieu Revest; Matthieu Saada; Marie-Line Erpelding; Christine Selton-Suty; Coralie Bouchiat; François Delahaye; Catherine Chirouze; François Alla; Christophe Strady; Bruno Hoen
Abstract Objective: To analyze the characteristics and outcome of infective endocarditis (IE) according to the time interval between IE first symptoms and diagnosis. Methods: Among the IE cases of a French population-based epidemiological survey, patients having early-diagnosed IE (diagnosis of IE within 1 month of first symptoms) were compared with those having late-diagnosed IE (diagnosis of IE more than 1 month after first symptoms). Results: Among the 486 definite-IE, 124 (25%) had late-diagnosed IE whereas others had early-diagnosed IE. Early-diagnosed IE were independently associated with female gender (OR = 1.8; 95% CI [1.0–3.0]), prosthetic valve (OR= 2.6; 95% CI [1.4–5.0]) and staphylococci as causative pathogen (OR = 3.7; 95% CI [2.2–6.2]). Cardiac surgery theoretical indication rates were not different between early and late-diagnosed IE (56.3% vs 58.9%), whereas valve surgery performance was lower in early-diagnosed IE (41% vs 53%; p = .03). In-hospital mortality rates were higher in early-diagnosed IE than in late-diagnosed IE (25.1% vs 16.1%; p < .001). Conclusions: The time interval between IE first symptoms and diagnosis is closely related to the IE clinical presentation, patient characteristics and causative microorganism. Better prognosis reported in late-diagnosed IE may be related to a higher rate of valvular surgery. KEY MESSAGES Infective endocarditis, which time interval between first symptoms and diagnosis was less than one month, were mainly due to Staphylococcus aureus in France. Staphylococcus aureus infective endocarditis were associated with septic shock, transient ischemic attack or stroke and higher mortality rates than infective endocarditis due to other bacteria or infective endocarditis, which time interval between first symptoms and diagnosis was more than one month. Infective endocarditis, which time interval between first symptoms and diagnosis was more than one month, were accounting for one quarter of all infective endocarditis in our study and were associated with vertebral osteomyelitis and a higher rate of cardiac surgery performed for hemodynamic indication than other infective endocarditis.
Frontiers of Medicine in China | 2016
Brice Guerpillon; André Boibieux; Clemence Guenne; Christine Ploton; Tristan Ferry; Max Maurin; Emmanuel Forestier; Olivier Dauwalder; Patrick Manipoud; Aicha Ltaïef-Boudrigua; Robert Gürkov; François Vandenesch; Coralie Bouchiat
We report here three unusual cases of otomastoiditis due to Francisella tularensis, complicated by cervical abscesses and persistent hearing loss, plus facial paralysis for one patient. Intriguingly, the three patients had practiced canyoneering independently in the same French river, between 2009 and 2014, several days before clinical symptoms onset. The results point out that fresh water exposure may be a potential contamination route for tularemia. Besides, due to the frequent complications and sequelae, we believe that F. tularensis should be considered as a possible etiology in case of otitis media, failure of the conventional antibiotic treatment, and suspicious exposure of the bacteria.
Toxins | 2015
Johan Courjon; Patrick Munro; Yvonne Benito; Orane Visvikis; Coralie Bouchiat; Laurent Boyer; Anne Doye; Hubert Lepidi; Eric Ghigo; Jean-Philippe Lavigne; François Vandenesch; Emmanuel Lemichez
It is crucial to define risk factors that contribute to host invasion by Staphylococcus aureus. Here, we demonstrate that the chromosomally encoded EDIN-B isoform from S. aureus contributes to the onset of bacteremia during the course of pneumonia. Deletion of edinB in a European lineage community-acquired methicillin resistant S. aureus (CA-MRSA) strain (ST80-MRSA-IV) dramatically decreased the frequency and magnitude of bacteremia in mice suffering from pneumonia. This deletion had no effect on the bacterial burden in both blood circulation and lung tissues. Re-expression of wild-type EDIN-B, unlike the catalytically inactive mutant EDIN-R185E, restored the invasive characteristics of ST80-MRSA-IV.
The Journal of Infectious Diseases | 2014
Coralie Bouchiat; Chloé Mehenni; Hélène Meugnier; Michèle Bes; Anne Tristan; François Vandenesch
the prevention and treatment of invasive fungal infections. Immunotherapy 2012; 4:1869–82. 11. Dierdorf R. A role for granulocyte-macrophage colony-stimulating factor (GM-CSF) in the treatment of neutropenic patients with pneumonia. Braz J Infect Dis 1997; 1:68–76. 12. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Intranasal granulocyte-macrophage colonystimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52:716–8. 13. Roux D. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009; 37:1062–7. 14. Richardson MD. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. J Med Vet Mycol 1992; 30:433–41. 15. Derouet M. Granulocyte macrophage colonystimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem 2004; 279:26915–21. 16. Klein JB. Granulocyte-macrophage colonystimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J Immunol 2000; 164:4286–91. 17. Tyner JW. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 2005; 11:1180–7. 18. Jamieson AM, Pasman L, Yu S, et al. Role of tissue protection in lethal respiratory viralbacterial coinfection. Science 2013; 340: 1230–4. 19. Whitsett JA. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 2010; 61:105–19. 20. Monticelli LA, Sonnenberg GF, Abt MC, et al. Innate lymphoid cells promote lungtissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045–54. 21. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005; 171:1142–9. 22. Wylam ME, Ten R, Prakash UB, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 2006; 27:585–93. 23. Tazawa R, Inoue Y, Arai T, et al. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled GM-CSF therapy. Chest 2014; 145:729–37.
Frontiers in Microbiology | 2018
Karen Moreau; Alisson Clemenceau; Vincent Le Moing; David Messika-Zeitoun; Paal Skytt Andersen; Niels Eske Bruun; Robert Skov; Florence Couzon; Coralie Bouchiat; Marie L. Erpelding; Alex van Belkum; Yohan Bossé; Xavier Duval; François Vandenesch; Cofrasa Study Groups
Staphylococcus aureus infective endocarditis (SaIE) is a severe complication of S. aureus bacteremia (SAB) occurring in up to 22% of patients. Bacterial genetic factors and host conditions for SaIE have been intensely studied before; however, to date no study has focused on predisposing host genetic factors to SaIE. The present study aimed to identify genetic polymorphisms associated with SaIE by a Genome-Wide Association Study (GWAS) of 67 patients with definite native valve SaIE (cases) and 72 matched native valve patients with SAB but without IE (controls). All patients were enrolled in the VIRSTA cohort (Le Moing et al., 2015) study. Four single nucleotide polymorphisms (SNPs) located on chromosome 3 were associated with SaIE (P < 1 × 10-5) without reaching conventional genome-wide significance. For all, the frequency of the minor allele was lower in cases than in controls, suggesting a protective effect of the minor allele against SaIE. The same association was observed using an independent Danish verification cohort of SAB with (n = 57) and without (n = 123) IE. Ex vivo analysis of aortic valve tissues revealed that SaIE associated SNPs mentioned above were associated with significantly higher mRNA expression levels of SLC7A14, a predicted cationic amino acid transporter protein. Taken together, our results suggest an IE-protective effect of SNPs on chromosome 3 during the course of SAB. The effects of protective minor alleles may be mediated by increasing expression levels of SLC7A14 in valve tissues. We conclude that occurrence of SaIE may be the combination of a well-adapted bacterial genotype to a susceptible host.
Journal of the American College of Cardiology | 2016
François Delahaye; Coralie Bouchiat; Brice Guerpillon; François Vandenesch
We are thankful to Dr. Baty for his interest in our work [(1)][1] and for questioning our systematic approach to treating portals of entry (POEs) to prevent new episodes of infective endocarditis (IE). Dr. Baty mentions “a colonic lesion in only 1 of 75 patients with an SIE [staphylococcal
Open Forum Infectious Diseases | 2015
Coralie Bouchiat; Julien Saison; Sandrine Boisset; Jean-Pierre Flandrois; Bertrand Issartel; Olivier Dauwalder; Yvonne Benito; Sophie Jarraud; Jacqueline Grando; Andre Boibieux; Oana Dumitrescu; François Delahaye; Fadi Farhat; Françoise Thivolet-Béjui; Jean-Philippe Frieh; François Vandenesch
From 2010 to 2013, 5 cases of nontuberculous mycobacteria infective endocarditis (IE), exclusively from bioprosthesis, were diagnosed in three hospitals out of 370 blood culture-negative-suspected IE. The porcine origin of this underestimated etiology is questioned.